Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant

References

• Altmüller A, Kunerl M, Müller K, Hinshaw VS, Fitch WM, Scholtissek C. Genetic relatedness of the nucleoprotein (NP) of recent swine, turkey, and human influenzaA virus (H1N1) isolates. Virus Res 1992; 22(1):79-87; PMID:1536092; http://dx.doi.org/10.1016/0168-1702(92)90091-M
   PubMedGoogle Scholar
• Yewdell JW, Bennink JR, Smith GL, Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci 1985; 82(6):1785-9; PMID:3872457; http://dx.doi.org/10.1073/pnas.82.6.1785
   PubMed Web of Science ®Google Scholar
• Influenza report 2006. ISBN 3-924774-51-X, http://www.influenzareport.com.
   Google Scholar
• Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12(1):48-54; PMID:16494717; http://dx.doi.org/10.3201/eid1201.051237
   PubMed Web of Science ®Google Scholar
• Guo L, Zheng M, Ding Y, Li D, Yang Z, Wang H, Chen Q, Sui Z, Fang F, Chen Z. Protection against multiple influenza A subtypes by intranasal administration of recombinant nucleoprotein. Arch Virol 2010; 155(11):1765-75; PMID:20652335; http://dx.doi.org/10.1007/s00705-010-0756-3
   PubMedGoogle Scholar
• Roose K, Fiers W, Saelens X. Pandemic preparedness: toward a universal influenza vaccine. Drug News Perspect 2009; 22(2):80-92; PMID:19330167; http://dx.doi.org/10.1358/dnp.2009.22.2.1334451
   PubMedGoogle Scholar
• Chen Q, Kuang H, Wang H, Fang F, Yang Z, Zhang Z, Zhang X, Chen Z. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 2009; 38:30-8; PMID:19067149; http://dx.doi.org/10.1007/s11262-008-0305-2
   PubMed Web of Science ®Google Scholar
• Chen Z, Yoshikawa T, Kadowaki S, Hagiwara Y, Matsuo K, Asanuma H, Aizawa C, Kurata T, Tamura S. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 1999; 80(Pt 10):2559-64; PMID:10573147
   PubMed Web of Science ®Google Scholar
• Zheng M, Luo J, Chen Z. Development of universal influenza vaccines based on influenza virus M and NP genes. Infection 2014; 42(2):251-62; PMID:24178189; http://dx.doi.org/10.1007/s15010-013-0546-4
   PubMed Web of Science ®Google Scholar
• Kim TJ, Kim KH, Lee JI. Stimulation of mucosal and systemic antibody responses against recombinant transferrin-binding protein B of Actinobacillus pleuropneumoniae with chitosan after tracheal administration in piglets. J Vet Med Sci 2007; 69(5):535-9; PMID:17551229; http://dx.doi.org/10.1292/jvms.69.535
   PubMedGoogle Scholar
• Meng S, Liu Z, Xu L, Li L, Mei S, Bao L, Deng W, Li L, Lei R, Xie L, et al. Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice. PLoS One 2011; 6(5):e19863; PMID:21625486; http://dx.doi.org/10.1371/journal.pone.0019863
   PubMedGoogle Scholar
• McLachlan JB, Shelburne CP, Hart JP, Pizzo SV, Goyal R, Brooking-Dixon R, Staats HF, Abraham SN. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 2008; 14(5):536-41; PMID:18425129; http://dx.doi.org/10.1038/nm1757
   PubMed Web of Science ®Google Scholar
• Powell TJ, Strutt T, Reome J, Hollenbaugh J, Roberts AD, Woodland DL, Swain SL, Dutton RW. Priming with Cold-Adapted Influenza A Does Not Prevent Infection but Elicits Long-Lived Protection against Supralethal Challenge with Heterosubtypic Virus. J Immunol 2007; 178:1030-8; PMID:17202366; http://dx.doi.org/10.4049/jimmunol.178.2.1030
   PubMed Web of Science ®Google Scholar
• Wraith DC, Vessey AE, Askonas BA. Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol 1987; 68(2):433-40; PMID:3493324; http://dx.doi.org/10.1099/0022-1317-68-2-433
   PubMedGoogle Scholar
• LaMere MW, Lam HT, Moquin A, Haynes L, Lund FE, Randall TD, Kaminski DA. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 2011; 186(7):4331-9; PMID:21357542; http://dx.doi.org/10.4049/jimmunol.1003057
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Coudret CL, Fletcher DR. Intracellular Neutralization of Influenza Virus by Immunoglobulin A Anti-Hemagglutinin Monoclonal Antibodies. J Virol 1995; 69(2):1339-43; PMID:7815518
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci 1992; 89:6901-5; PMID:1323121; http://dx.doi.org/10.1073/pnas.89.15.6901
   PubMed Web of Science ®Google Scholar
• Tamura SI, Miyata K, Matsuo K, Asanuma H, Takahashi H, Nakajima K, Suzuki Y, Aizawa C, Kurata T. Acceleration of Influenza Virus Clearance by Thl Cells in the Nasal Site of Mice Immunized Intranasally with Adjuvant-Combined Recombinant Nucleoprotein. J Immunol 1996; 156:3892-900; PMID:8621928
   PubMed Web of Science ®Google Scholar
• Mukhtar MM, Li S, Li W, Wan T, Mu Y, Wei W, Kang L, Rasool ST, Xiao Y, Zhu Y, et al. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. Int J Biochem Cell Biol 2009; 41(3):554-60; PMID:18687409; http://dx.doi.org/10.1016/j.biocel.2008.07.001
   PubMedGoogle Scholar
• Sui Z, Chen Q, Fang F, Zheng M, Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010; 28(48):7690-8; PMID:20870054; http://dx.doi.org/10.1016/j.vaccine.2010.09.019
   PubMed Web of Science ®Google Scholar
• Sui Z, Chen Q, Fang F, Zheng M, Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010; 28(48):7690-8; PMID:20870054; http://dx.doi.org/10.1016/j.vaccine.2010.09.019
   PubMed Web of Science ®Google Scholar
• Baltzly R, Buck JS, de Beer EJ. A family of long-acting depressors. J Am Chem Soc 1949; 71(4):1301-5; PMID:18128356; http://dx.doi.org/10.1021/ja01172a045
   PubMedGoogle Scholar
• Echtenacher B, Mannel DN. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381:75-7; PMID:8609992; http://dx.doi.org/10.1038/381075a0
   PubMed Web of Science ®Google Scholar
• Malaviya R, Ikeda T, Ross E. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-a. Nature 1996; 381:77-80; PMID:8609993; http://dx.doi.org/10.1038/381077a0
   PubMed Web of Science ®Google Scholar
• McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham SN. Mast cell-derived tumor necrosis factor induces hypertrophy ofdraining lymph nodes during infection. Nat Immunol 2003; 4:1199-1205; PMID:14595438; http://dx.doi.org/10.1038/ni1005
   PubMed Web of Science ®Google Scholar
• Xu L, Bao L, Li F, Lv Q, Yuan J, Xu Y, Deng W, Yao Y, Yu P, Qin C. Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. Immunol Invest 2014; 43(3):224-35; PMID:24295504; http://dx.doi.org/10.3109/08820139.2013.859155
   PubMed Web of Science ®Google Scholar
• Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun 2006; 343(4):1124-31; PMID:16580631; http://dx.doi.org/10.1016/j.bbrc.2006.03.088
   PubMedGoogle Scholar
• Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice. BMC Infect Dis 2009; 9:17; PMID:19216752; http://dx.doi.org/10.1186/1471-2334-9-17
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgran quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3
   PubMed Web of Science ®Google Scholar
• Zhu Q, Chang H, Chen Y, Fang F, Xue C, Zhang F, Qiu M, Wang H, Wang B, Chen Z. Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice. Biochem Biophys Res Commun 2005; 329:87-9; PMID:15721277; http://dx.doi.org/10.1016/j.bbrc.2005.01.109
   PubMedGoogle Scholar
• Deng YJ, Yewdell W, Eisenlohr LC, et al. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 1997; 158:1507-1515; PMID:9029084
   PubMed Web of Science ®Google Scholar
• Gao XM, Liew FY, Tite JP. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol 1989; 143:3007-3014; PMID:2478631
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang F, Fang F, Chang H, Chen Z. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 2007; 7:118; PMID:17939857; http://dx.doi.org/10.1186/1471-2334-7-118
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen J, Fang F, Zhou Y, Wu J, Chang H, Zhang R, Wang F, Li X, Wang H, et al. Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 2005; 24:758-65; PMID:16274296; http://dx.doi.org/10.1089/dna.2005.24.758
   PubMedGoogle Scholar